T. Rowe Price Associates’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $818M | Sell |
|
|||||
|
2025
Q2 | $1.18B | Buy |
|
|||||
|
2025
Q1 | $1.07B | Buy |
|
|||||
|
2024
Q4 | $799M | Buy |
|
|||||
|
2024
Q3 | $691M | Buy |
|
|||||
|
2024
Q2 | $622M | Buy |
|
|||||
|
2024
Q1 | $492M | Buy |
|
|||||
|
2023
Q4 | $364M | Buy |
|
|||||
|
2023
Q3 | $306M | Buy |
|
|||||
|
2023
Q2 | $248M | Buy |
|
|||||
|
2023
Q1 | $202M | Buy |
|
|||||
|
2022
Q4 | $110M | Buy |
|
|||||
|
2022
Q3 | $71.7M | Buy |
|
|||||
|
2022
Q2 | $68.7M | Sell |
|
|||||
|
2022
Q1 | $90.2M | Sell |
|
|||||
|
2021
Q4 | $247M | Sell |
|
|||||
|
2021
Q3 | $253M | Sell |
|
|||||
|
2021
Q2 | $266M | Sell |
|
|||||
|
2021
Q1 | $252M | Sell |
|
|||||
|
2020
Q4 | $513M | Sell |
|
|||||
|
2020
Q3 | $1.61B | Buy |
|
|||||
|
2020
Q2 | $1B | Buy |
|
|||||
|
2020
Q1 | $553M | Buy |
|
|||||
|
2019
Q4 | $728M | Sell |
|
|||||
|
2019
Q3 | $710M | Buy |
|
|||||
|
2019
Q2 | $591M | Buy |
|
|||||
|
2019
Q1 | $411M | Buy |
|
|||||
|
2018
Q4 | $322M | Buy |
|
|||||
|
2018
Q3 | $309M | Buy |
|
|||||
|
2018
Q2 | $189M | Buy |
|
|||||
|
2018
Q1 | $64.4M | Sell |
|
|||||
|
2017
Q4 | $116M | Buy |
|
|||||
|
2017
Q3 | $70.2M | Sell |
|
|||||
|
2017
Q2 | $69.5M | Sell |
|
|||||
|
2017
Q1 | $63.5M | Sell |
|
|||||
|
2016
Q4 | $55.4M | Sell |
|
|||||
|
2016
Q3 | $61M | Buy |
|
|||||
|
2016
Q2 | $58.5M | Buy |
|
|||||
|
2016
Q1 | $46M | Sell |
|
|||||
|
2015
Q4 | $45.1M | Buy |
|
|||||
|
2015
Q3 | $39.9M | Buy |
|
|||||
|
2015
Q2 | $41.7M | Buy |
|
|||||
|
2015
Q1 | $41.2M | Buy |
|
|||||
|
2014
Q4 | $29.5M | Sell |
|
|||||
|
2014
Q3 | $62.9M | Sell |
|
|||||
|
2014
Q2 | $68.3M | Sell |
|
|||||
|
2014
Q1 | $73.9M | Buy |
|
|||||
|
2013
Q4 | $57.5M | Sell |
|
|||||
|
2013
Q3 | $157M | Buy |
|
|||||
|
2013
Q2 | $86.8M | Buy |
|